Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AE.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.407NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.423NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.281NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.230NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.535NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.564.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.345NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.450NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.334NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
B.1.589NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.335NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.169NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.442NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.75NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.106NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.593NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.438.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.423NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.550NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.261NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.3.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.15.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCBNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XSNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used